Familia Imara: A Parenting Program to Reduce Family Violence in Tanzania

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorSaini Das

About this trial

This cluster-randomized controlled trial will evaluate the effectiveness, implementation, and scalability of Familia Imara, a group-based, couples-focused, community health worker (CHW)-delivered parenting program, on reducing intimate partner violence (IPV), harsh discipline, and improving child development and nutrition outcomes in the Mara and Geita regions of Tanzania. Villages will be randomly assigned to either an intervention or control arm. The study will be implemented in two sequential cohorts. In Cohort 1, a traditional randomized controlled trial will compare intervention villages receiving the program to control villages receiving no intervention (waitlist control), with delivery supported primarily by implementing partners in collaboration with government supervisors. In Cohort 2, the same villages will retain their original assignment. Intervention villages will receive the program under a government-led delivery model to assess scalability and integration into existing systems, while control villages will transition from waitlist to receive the intervention. Evidence generated will inform policy and practice for preventing family violence and promoting early childhood development at scale.

Eligibility criteria

Qualifiers

The household has a child aged 0-24 months at enrollment

The child has a primary female caregiver (i.e., mother) and a primary male caregiver (i.e., father) who are in a partnered relationship

Primary female caregiver, primary male caregiver, and child reside together in the same household

Both caregivers provide written informed consent for themselves and their child to participate in the study

Disqualifiers

Need to satisfy the inclusion criteria

Expecting to relocate in the next year

Trial design

Treatments tested in this trial

  • Familia Imara

Treatment groups

6,216 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Saini Das

Lead sponsor

George Washington University

Sponsor institution

Emory University

Collaborator

National Institute of Medical Research

Collaborator

The Prevention Collaborative

Collaborator

Global Communities

Collaborator

Kivulini Women's Right Organization

Collaborator